Mary Miller, Chief Legal Officer at Acrivon Therapeutics, Inc. (ACRV), sold 294 shares at $1.99 ($585) on 2026-10-05, disclosed to the SEC on 2026-10-07.
Seasonal sale ($585) by Chief Legal Officer — this insider has traded ACRV in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BFLY | SELL | 2022-02-17 | $198K | — | Filing → |